Maybe investors are casting a more critical eye on MXC announcements that don't add much to the story.
ArtemiC is really nothing more than another Aspro in reality if its effects are zero for very ill COVID-19 patients.
No one seems to want to toch that bit of the report on this forum - that tells its own story.
